Wearable technologies are one such avenue that will further strengthen the foundation of capturing, detecting, and processing biomarker indices (IL-6, IL-8, TNF-α, IL-10 and CRP) in real-time.
Biomarkers will revolutionize the process of detecting cytokine storms in COVID-19 patients.
Disease detection with the help of wearable technology in a non-invasive manner is still in nascent stages and a lot of research is being carried out in this space.
The next step for researchers is to test the sensor in more people and validate their initial findings in patients.
In summary, with our new normal it will be far more crucial to get an accurate and timely diagnosis as the new approach for early detection is still being examined.
Achieving a greater level of sensitivity and specificity in these sensors will be a challenge and an opportunity at the same time to revolutionize the way we diagnose critical diseases like COVID-19.